196
Views
7
CrossRef citations to date
0
Altmetric
Editorial

To switch (statins) or not to switch? That is the question

, , &
Pages 2943-2946 | Published online: 19 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elizabeth Marrett, Changgeng Zhao, Ning Jackie Zhang, Qiaoyi Zhang, Dena R Ramey, Joanne E Tomassini, Andrew M Tershakovec & David R Neff. (2014) Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US. Vascular Health and Risk Management 10, pages 237-246.
Read now
JoAnne M Foody, Peter P Toth, Joanne E Tomassini, Shiva Sajjan, Dena R Ramey, David Neff, Andrew M Tershakovec, Henry Hu & Kaan Tunceli. (2013) Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. Vascular Health and Risk Management 9, pages 719-727.
Read now

Articles from other publishers (5)

Michael G. Kirby, Paula Allchorne, Tim Appanna, Patrick Davey, Richard Gledhill, James S. A. Green, Damian Greene & Derek J. Rosario. (2019) Prescription switching: Rationales and risks. International Journal of Clinical Practice 74:1.
Crossref
Christopher P. Cannon, James A. de Lemos, Robert S. Rosenson, Christie M. Ballantyne, Yuyin Liu, Daniel Yazdi, Mary Elliott-Davey, Katherine E. Mues, Deepak L. Bhatt & Mikhail N. Kosiborod. (2020) Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States. American Heart Journal 219, pages 70-77.
Crossref
Peter P. Toth, JoAnne M. Foody, Joanne E. Tomassini, Shiva G. Sajjan, Dena R. Ramey, David R. Neff, Andrew M. Tershakovec, X. Henry Hu & Kaan Tunceli. (2014) Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease. Journal of Clinical Lipidology 8:1, pages 107-116.
Crossref
Amit R. Rahalkar, Matthew R. Ban & Robert A. Hegele. (2013) Clinical Equivalence of Proprietary and Generic Atorvastatin in Lipid Clinic Patients. Canadian Journal of Cardiology 29:4, pages 418-422.
Crossref
. (2011) Current World Literature. Current Opinion in Cardiology 26:4, pages 356-361.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.